BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

LabConnect Launches LabConnector™ to Transform Clinical Trial Data Management

LabConnect, LLC, a global leader in central laboratory services for clinical trials, announced the launch of LabConnector™, a powerful new techn...

August 20, 2025 | News

Mabwell Secures FDA IND Clearance for CDH17-Targeting ADC 7MW4911 in Advanced GI Cancers

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D cod...

August 20, 2025 | News

Ascletis Reports 44.8% Weight Reduction in Obese Mouse Model with Combination of ASC47 and Novel Dual GLP-1R/GIPR Agonist ASC31

Combination of a low dose of ASC47 with ASC31, a novel peptide agonist targeting both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR), ...

August 19, 2025 | News

IQVIA and Veeva Forge Global Clinical and Commercial Partnerships, Resolve Legal Disputes

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Und...

August 19, 2025 | News

WuXi XDC Delivers 62% Revenue Growth and Record Project Momentum in H1 2025

- Revenue increased by 62.2% YoY to RMB 2,701 million - Gross profit surged by 82.2% YoY to RMB 975 million, with i...

August 19, 2025 | Company results

GenScript Biotech CEO Sherry Shao Champions Innovation and Global Expansion as H1 2025 Profits Surge Over 500%

GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 20...

August 18, 2025 | Company results

Novo Nordisk’s Wegovy® Becomes First and Only GLP-1 Therapy Approved for MASH with Moderate to Advanced Fibrosis

Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with modera...

August 18, 2025 | News

SineuGene Secures Dual U.S. and China IND Clearances for First-in-Class ALS Gene Therapy SNUG01

SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, anno...

August 18, 2025 | News

Philips to Invest $150M in U.S. Manufacturing and R&D to Advance AI-Enabled Ultrasound and Create Over 270 Jobs

Philips, a global leader in health technology, announced a plan for new investments of more than USD 150 million in U.S. manufacturing and research an...

August 15, 2025 | News

Clarivate launches beta of AI Regulatory Assistant in Cortellis

Clarivate Plc , a leading global provider of transformative intelligence, announced the beta launch of its AI-powered Regulatory Assistant ...

August 15, 2025 | News

Leads Biolabs Completes Patient Enrollment in World’s First Registrational Trial of Immunotherapy for Advanced EP-NEC

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced the successful completion of patient enrollment in t...

August 15, 2025 | News

Remegen’s Telitacicept Hits Phase III Milestone in Primary Sjögren’s Syndrome

Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met the primary endp...

August 14, 2025 | News

Fosun Pharma Licenses XH-S004 to Expedition in US$645M Deal

Fosun Pharma announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) t...

August 13, 2025 | News

Sartorius Stedim Biotech Partners with Nanotein to Advance Immune Cell Manufacturing with NanoSpark® Reagents

Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for...

August 12, 2025 | News

Stay Connected